A pseudarthrosis is defined as a non healing fracture from which a false joint develops. It is manifested if healing of a fracture has not been achieved within six months after fracture development. Nonunions occur in 5% to 10% of all fractur patients. They are usually very painful and limit the mobility of concerned patients.
The current standard of care for the treatment of pseudarthrosis comprises debridement of the pseudarthrotic tissue, cleaning of the fragments edges, insertion of autologous spongiosa and stabilization with osteosynthesis material. However, these surgical procedurces are very costly as well as time consuming, are associated with a high complication rate and last but not least extremly traumatic for the patient. Consequently there is a high interest in a non-invasive, effective and efficient treatment option for pseudarthrosis. MTS’ Spark Wave™ therapy with orhtogold280 represents such a therapy method.